Organon Beats On Q1, Women's Health Leads the Charge - Organon (NYSE:OGN)
Organon reported 5% increase in Q1 2024 revenue of $1.622 billion, beating consensus. EPS of $1.22 and dividend of $0.28 declared.
Source: benzinga.com
Volume Based Procurement News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Volume Based Procurement. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Volume Based Procurement Today - Breaking & Trending Today
Organon Reports Results for the First Quarter Ended March 31, 2024
First quarter 2024 revenue of $1,622 million, up 5% on an as-reported basis and 7% at constant currency First quarter 2024 diluted earnings per share of $0.78 and non-GAAP Adjusted diluted...
Source: marketscreener.com
Balanced Outlook: Hold Rating Justified for Smith & Nephew Amidst Growth and Market Challenges
Caitlin Cronin, an analyst from Canaccord Genuity, maintained the Hold rating on Smith & Nephew Snats (SNN – Research Report). The as...
Source: businessinsider.com
Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2023
Full year 2023 revenue of $6.3 billion, up 1% as-reported and 3% at constant currency Full year 2023 diluted earnings per share of $3.99 and non-GAAP Adjusted diluted earnings per share of...
Source: marketscreener.com
Organon Reports Results for the Third Quarter Ended September 30, 2023
Third quarter 2023 revenue of $1,519 million Third quarter 2023 diluted earnings per share of $0.23 and non-GAAP Adjusted diluted earnings per share of $0.87 Adjusted EBITDA of $447...
Source: marketscreener.com